WO2015166419A3 - Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor - Google Patents

Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor Download PDF

Info

Publication number
WO2015166419A3
WO2015166419A3 PCT/IB2015/053098 IB2015053098W WO2015166419A3 WO 2015166419 A3 WO2015166419 A3 WO 2015166419A3 IB 2015053098 W IB2015053098 W IB 2015053098W WO 2015166419 A3 WO2015166419 A3 WO 2015166419A3
Authority
WO
WIPO (PCT)
Prior art keywords
pain
pharmaceutical composition
tramadol hydrochloride
ketorolac tromethamine
production method
Prior art date
Application number
PCT/IB2015/053098
Other languages
English (en)
French (fr)
Other versions
WO2015166419A2 (es
Inventor
Oliver Daniel WALLS FLORES
Ramón RODRÍGUEZ HERNÁNDEZ
Eduardo BARRENA HERNÁNDEZ
Original Assignee
Laboratorios Liomont, S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54359445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2015166419(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liomont, S.A. De C.V. filed Critical Laboratorios Liomont, S.A. De C.V.
Publication of WO2015166419A2 publication Critical patent/WO2015166419A2/es
Publication of WO2015166419A3 publication Critical patent/WO2015166419A3/es
Priority to SV2016005309A priority Critical patent/SV2016005309A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Abstract

Una composición farmacéutica oral de la combinación de ketrolaco trometamina / clorhidrato de tramadol para el tratamiento de alopatías relacionadas con el dolor (de moderado a severo), analgésico, antiinflamatorio, fiebre o antipirética, para su administración oral y en específico como una tableta sublingual.
PCT/IB2015/053098 2014-04-29 2015-04-29 Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor WO2015166419A2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SV2016005309A SV2016005309A (es) 2014-04-29 2016-10-28 Proceso de obtenciã“n y composiciã“n farmacã‰utica para de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2014005153A MX2014005153A (es) 2014-04-29 2014-04-29 Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
MXMX/A/2014/005153 2014-04-29

Publications (2)

Publication Number Publication Date
WO2015166419A2 WO2015166419A2 (es) 2015-11-05
WO2015166419A3 true WO2015166419A3 (es) 2016-01-07

Family

ID=54359445

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/053098 WO2015166419A2 (es) 2014-04-29 2015-04-29 Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor

Country Status (4)

Country Link
CL (1) CL2016002656A1 (es)
MX (1) MX2014005153A (es)
SV (1) SV2016005309A (es)
WO (1) WO2015166419A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2607661C1 (ru) * 2015-11-30 2017-01-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) Ректальные суппозитории, обладающие болеутоляющим действием
MX2018003456A (es) 2017-12-21 2019-09-06 Gruenenthal Gmbh Combinacion farmaceutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y tramadol clorhidrato, y su uso para el tratamiento del dolor.
MX2018000963A (es) 2018-01-22 2018-12-13 Federico Amezcua Amezcua Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008120966A1 (es) * 2007-04-02 2008-10-09 Espinosa Abdala Leopoldo De Jesus Composición farmacéutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgésico opiáceo para el manejo del dolor.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008120966A1 (es) * 2007-04-02 2008-10-09 Espinosa Abdala Leopoldo De Jesus Composición farmacéutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgésico opiáceo para el manejo del dolor.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GAMMADOL: "prospecto, efectos adversos, preguntas frecuentes;", 25 November 2013 (2013-11-25), Retrieved from the Internet <URL:http://www.doctoralia.com.mx/medicamento/gammadol-54051> [retrieved on 20151020] *

Also Published As

Publication number Publication date
CL2016002656A1 (es) 2017-02-17
WO2015166419A2 (es) 2015-11-05
MX2014005153A (es) 2015-10-28
SV2016005309A (es) 2017-05-15

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
MY196173A (en) Cot Modulators And Methods Of Use Thereof
WO2015077503A8 (en) Autotaxin inhibitor compounds
WO2011104652A3 (en) Veterinary compositions
IL285899A (en) Pharmaceutical dosage form for application to mucous membranes and methods for its production
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
MX2021008432A (es) Composiciones farmaceuticas y usos dirigidos a los trastornos del almacenamiento lisosomal.
EP3725297A4 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING PEMETREXED AND RELATED PRODUCTION PROCESS
IN2015DN01023A (es)
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
WO2015166419A3 (es) Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
WO2015166418A3 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
MX2015015681A (es) Composicion farmaceutica que comprende fingolimod.
WO2015114656A3 (en) Mucoadhesive tablet of pregabalin
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
WO2018069805A3 (en) Method for preparation of liquid oral composition of l-thyroxin
WO2019132729A3 (ru) Фармацевтические композиции на основе ментилового эфира индометацина и его применение
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
MX2017001192A (es) Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.
WO2015004634A3 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
MX2011006758A (es) Composicion farmaceutica para uso en inflamacion y dolor.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15786382

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15786382

Country of ref document: EP

Kind code of ref document: A2